ERAD Therapeutics Inc. is focusing on the development for therapeutics for Orphan Diseases, based on the discovery at the Hospital for Sick Children in Toronto, Canada that certain bacterial proteins could be exploited to rescue mis-folded but functional proteins and help restore normal cellular function in diseases such as Gaucher Disease and Cystic Fibrosis. We continue to strengthen our platform technology to bring new therapeutic inventions and hope to patients with these (and other) rare genetic diseases.

• What is an Orphan Drug?
• Orphan Drug Overview
• Advantages of Orpan Drug Development